checkAd

     129  0 Kommentare Oncternal Therapeutics Adds Matthew Smith, M.D., Ph.D. to its Prostate Cancer Scientific Advisory Board - Seite 3

    Contact Information:

    Investors
    Richard Vincent
    Chief Financial Officer
    858-434-1113
    rvincent@oncternal.com

    Lesen Sie auch

    Media
    Corey Davis, Ph.D.
    LifeSci Advisors
    212-915-2577        
    cdavis@lifesciadvisors.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Oncternal Therapeutics Adds Matthew Smith, M.D., Ph.D. to its Prostate Cancer Scientific Advisory Board - Seite 3 SAN DIEGO, Oct. 25, 2023 (GLOBE NEWSWIRE) - Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the addition of Matthew Smith, M.D., Ph.D. …